0000880771-16-000200.txt : 20161027
0000880771-16-000200.hdr.sgml : 20161027
20161027130006
ACCESSION NUMBER: 0000880771-16-000200
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20161025
FILED AS OF DATE: 20161027
DATE AS OF CHANGE: 20161027
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SCICLONE PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000880771
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943116852
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 950 TOWER LANE
STREET 2: SUITE 900
CITY: FOSTER CITY
STATE: CA
ZIP: 94404-2125
BUSINESS PHONE: 650-358-3456
MAIL ADDRESS:
STREET 1: 950 TOWER LANE
STREET 2: SUITE 900
CITY: FOSTER CITY
STATE: CA
ZIP: 94404-2125
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cheung Wilson Wai-Shun
CENTRAL INDEX KEY: 0001291656
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19825
FILM NUMBER: 161954768
MAIL ADDRESS:
STREET 1: SCICLONE PHARMACEUTICALS, INC.
STREET 2: 950 TOWER LANE, SUITE 900
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
4
1
certent-form4.xml
PRIMARY DOCUMENT
X0306
4
2016-10-25
0000880771
SCICLONE PHARMACEUTICALS INC
SCLN
0001291656
Cheung Wilson Wai-Shun
950 TOWER LANE, SUITE 900
FOSTER CITY
CA
94404
0
1
0
0
CFO & Senior VP, Finance
Common Stock
2016-10-25
4
S
0
70
10.00
D
15064
D
Common Stock
2016-10-26
4
S
0
15064
10
D
0
D
Common Stock
2016-10-26
4
M
0
45208
4.52
A
45208
D
Common Stock
2016-10-26
4
S
0
45208
10
D
0
D
Common Stock
2016-10-26
4
M
0
48995
5.97
A
48995
D
Common Stock
2016-10-26
4
S
0
48995
10
D
0
D
Common Stock
2016-10-26
4
M
0
40625
5.97
A
40625
D
Common Stock
2016-10-26
4
S
0
40625
10
D
0
D
Non-Qualified Stock Option (right to buy)
4.52
2016-10-26
4
M
0
45208
0
D
2024-03-14
Common Stock
45208
24792
D
Non-Qualified Stock Option (right to buy)
5.97
2016-10-26
4
M
0
40625
0
D
2023-07-16
Common Stock
40625
9375
D
Non-Qualified Stock Option (right to buy)
5.97
2016-10-26
4
M
0
48995
0
D
2023-08-09
Common Stock
48995
0
D
The reported sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 15, 2016.
Granted under the Issuer's 2005 Equity Incentive Plan.
25% of such shares vest from one year from the date of grant and 2.0833% vests each month thereafter, provided that the Reporting Person continues to be employed by the Issuer.
Provided Reporting Person remains employed by Issuer, the options will vest based upon the successful and timely filing by the SEC filing dates of the 10-Q and 10-Ks for the period from September 30, 2013 through the end of 2014, with the last 10-K filed for the year ending December 31, 2014 by March 16, 2015 (the "Performance Target"). If the Performance Target is not achieved, the options will not vest and will expire on March 17, 2015.
/s/ Wilson W. Cheung
2016-10-27